ASSESSING THE QUALITY OF LIFE OF HEPATOCELLULAR CARCINOMA PATIENTS TREATED AT MILITARY HOSPITAL 103 BY USING THE FACT-Hep QUESTIONNAIRE

Văn Diệu Nguyễn, Quốc Việt Nguyễn, Đức Anh Sầm, Quang Tùng Nguyễn, Huy Tâm Phan, Ngọc Khánh Nguyễn, Xuân Khái Nguyễn

Main Article Content

Abstract

Objectives: To assess the quality of life (QOL) of patients with hepatocellular carcinoma (HCC) treated at Military Hospital 103 from May 2024 to May 2025 using the FACT-Hep questionnaire. To study some factors related to QOL of HCC patients treated at Military Hospital 103 from May 2024 to May 2025. Subjects and methods: Cross-sectional descriptive study, collecting prospective data on 66 HCC patients who came for examination and were treated or periodically monitored at Military Hospital 103 from May 2024 to May 2025. Results: Average age of patients: 63,35 ± 10,37 years old; male/female ratio: 10/1; The total FACT-Hep score was 143,71 ± 16,20 points. The majority of patients (56,1%) had good QOL, while the number of patients with poor QOL was 29/66 (43,9%). Age, platelet index and tumor size concentration affect the QOL of HCC patients. Conclusion: The average QOL of HCC patients in the study was 143,71 ± 16,20 points. Most patients have good QOL (56,1%). Multivariate analysis showed that 3 factors were statistically significantly related to the QOL of HCC patients: age, platelet index and tumor size. These results emphasize the importance of monitoring and controlling these factors to improve the quality of life of HCC patients

Article Details

References

Bộ môn Nội tiêu hoá, Học viện Quân y, (2020). Hướng dẫn chẩn đoán và điều trị các mặt bệnh huấn luyện, đào tạo đại học chuyên ngành Nội tiêu hoá. Hà Nội.
2. Bộ Y tế (2020). Quyết định số 3129/QĐ-BYT của Bộ Y tế ngày 22 tháng 7 năm 2020 Về việc ban hành tài liệu chuyên môn “Hướng dẫn chẩn đoán và điều trị ung thư biểu mô tế bào gan nguyên phát”. Hà Nội.
3. Tôn Thất Ngọc (2021). Nghiên cứu giá trị của AFP, AFP-L3 và DCP trong chẩn đoán và điều trị ung thư biểu mô tế bào gan. Luận văn Tiến sĩ Y học. Trường Đại học Y Hà Nội.
4. Bray F, et al (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. 68(6): 394-424.
5. Cella D, et al (2012). Quality of life assessment in paients with hepatobiliary and pancreatic cancers using the FACT-Hep questionaire. Acta Chir Iugosl; 59(1): 41 – 45.
6. Heffernan N, et al (2002). Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol; 20(9): 2229-39.
7. Leung L, et al (2019). The association of liver function and quality of life of patients with liver cancer. BMC Gastroenterology; 19(1).
8. Steel JL, et al (2007). Health-related quality of life in patients with hepatocellular carcinoma: the impact of clinical factors. J Clin Oncol; 25(5):559-64.